Recurrent STAT3-JAK2 fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract
- PMID: 29592893
- PMCID: PMC5958657
- DOI: 10.1182/blood-2018-01-830968
Recurrent STAT3-JAK2 fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract
Conflict of interest statement
Conflict-of-interest disclosure: The authors declare no competing financial interests.
Figures

References
-
- Jaffe ES, Chott A, Ott G, et al. . Indolent T-cell lymphoproliferative disorder of the gastrointestinal tract. In: Swerdlow SH, Camp E, Harris NL, et al., eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: International Agency for Research on Cancer; 2017:379-380.
-
- Smith CA, Fan G. The saga of JAK2 mutations and translocations in hematologic disorders: pathogenesis, diagnostic and therapeutic prospects, and revised World Health Organization diagnostic criteria for myeloproliferative neoplasms. Hum Pathol. 2008;39(6):795-810. - PubMed
-
- Lacronique V, Boureux A, Valle VD, et al. . A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science. 1997;278(5341):1309-1312. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous